Center for Lawful Access and Abuse Deterrence
Home
About CLAAD
Overview
Information & Analysis
Coalition Building
Policy Leadership
Resources
Drug Facts
External Resources
National Strategy
Policy Activity
News
CLAAD in the News
Policy Brief
State & National News
Get Involved
Events
Our Coalition
Newsletter
Supporters
Contact Us
Drug Facts
External Resources
National Strategy
Policy Activity
CLAAD.org
Resources
Policy Activity
Risk Evaluation and Mitigation
FDA REMS Resources
REMS Statute
(April 30, 2009)
Labeling
CLAAD Letter to Congress on Labeling of Medications Introducing Impediments to Abuse
(March 24, 2010)
Novel Formulations
Overview of the Role of Abuse-Deterrent Medications in Addressing Prescription Drug Abuse
(December 29, 2011)
Current Status and Evolving Role of Abuse-Deterrent Opioids in Managing Patients with Chronic Pain
(May 2011)
Legal Liability Perspectives on Abuse-Deterrent Opioids in the Treatment of Chronic Pain
(December 2010)
Pharm. Cos. Must Apply Sci. & Tech. To Prevent Abuse
(October 2010)
Data Collection
Letter from Congressman Rogers and Congresswoman Bono Mack to the CDC
(January 20, 2011)
CLAAD Coalition Letter to CDC
(December 20, 2010)
Proposed Revisions to ICD
(December 20, 2010)
Prescription Monitoring Programs (PMPs)
CLAAD Letter to Council of State Governments Concerning PMPs
(January 14, 2011)
